AI/ML Innovations Inc. (AIMLF)
| Market Cap | 6.57M -50.3% |
| Revenue (ttm) | 120.07K -49.8% |
| Net Income | -4.70M |
| EPS | -0.02 |
| Shares Out | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 707,187 |
| Average Volume | 207,337 |
| Open | 0.0276 |
| Previous Close | 0.0250 |
| Day's Range | 0.0251 - 0.0276 |
| 52-Week Range | 0.0200 - 0.0880 |
| Beta | 0.78 |
| RSI | 46.35 |
| Earnings Date | Apr 1, 2026 |
About AI/ML Innovations
AI/ML Innovations Inc. operates in the digital healthcare business using artificial intelligence (AI) and machine learning (ML) in Canada. The company offers MaxYield, a device-agnostic ECG signal processing; and AI PrecisionPulse Neural Network for the analysis of biometric signals to detect cardiovascular anomalies and personalized health recommendations, as well as Health Gauge’s solutions that capture vital signs, such as blood pressure, heart rate, and pulse wave velocity. It also engages in the research and development of health and weara... [Read more]
Financial Performance
In fiscal year 2025, AI/ML Innovations's revenue was 167,307, a decrease of -72.12% compared to the previous year's 600,137. Losses were -4.59 million, 39.8% more than in 2024.
Financial numbers in CAD Financial StatementsNews
AIML Appoints Dr. Paul Dorian as Medical Innovation Architect and Head of the Medical Advisory Board
World Renowned Cardiologist and Research Leader to Guide Clinical Strategy, Product Innovation, and AI-Driven Cardiac Diagnostics TORONTO, ON / ACCESS Newswire / January 28, 2026 / AI/ML Innovations I...
AIML Subsidiary NeuralCloud Collaborates with Movesense to Expand Bundled ECG Solutions for Clinical and Wellness Markets
Collaboration enables integrated device-plus-AI offerings supporting scalable ECG analysis, visualization, and report generation Combination of single-lead wearable devices and AI algorithms creating ...
AIML subsidiary NeuralCloud Solutions Inc., Signs Non-Binding Commercial Term Sheet with Lakeshore Cardiology to Deploy CardioYield(TM) for AI-Powered Holter Analysis
Agreement positions NeuralCloud's AI-driven cardiac platform for Holter monitoring and ambulatory patient workflow. Partnership introduces CardioYield™ powered by MaxYield™ for automated, reliable Hol...
AI/ML Appoints Erik Suokas as Chief Operating Officer to Accelerate Commercial Execution and Operational Scale
Appointment Supports AIML's Commercial Execution and Operational Scale as the Company Advances Its AI-Driven Cardiac Platform Leadership Addition Aligns Revenue, Delivery, and Product Execution as AIM...
AIML Announces the Conclusion of Consulting Agreement and Leadership Transition for President & Chief Commercial Officer
TORONTO, ON / ACCESS Newswire / December 30, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) has announced that its consulting agreement with Campfire Propert...
Join AIML's Live Shareholder Update with Chairman & CEO Paul Duffy
A Look Back at Key Milestones and Successes Achieved in 2025 What's Ahead: Exciting Plans, Strategic Outlook, and Goals for 2026 Advancing the Next Phase of Commercialization TORONTO, ON / ACCESS News...
AIML subsidiary NeuralCloud Solutions Signs Commercial Term Sheet with Culminate H Labs to Deploy MaxYield(TM) and Insight360(TM) into INTRINSICA's DNA-Guided Biofeedback Wellness Ecosystem
This strengthens NeuralCloud's expansion into the global wellness and B2B health practitioner delivery model with high-fidelity cardiac signal processing and digital health integration. Partnership po...
AIML Subsidiary NeuralCloud Enters Pilot with Cornerstone Physiotherapy to Deploy MaxYield(TM) and Insight360(TM) for Elite Athlete Cardiac Performance Testing
Early collaboration supports development of Cornerstone's emerging athlete-performance program and extends NeuralCloud's ECG analytics into sports-science and human performance markets Pilot ties MaxY...
AIML Subsidiary NeuralCloud Signs Commercial Term Sheet With Equimetrics To Deploy Maxyield(TM) And Cardioyield(TM) Across Equine Cardiac Monitoring Platforms
Agreement expands NeuralCloud's AI-enhanced ECG signal-processing technology into veterinary health and elite equine performance markets Commercial integration expands MaxYield™ and CardioYield™ into ...
AI/ML Subsidiary Neural Cloud Begins Pilot at SickKids to Advance AI-Enabled Pediatric Cardiac Care
Pilot Project to Explore AI-Driven ECG Signal Processing and Predictive Deterioration Models in Pediatric Cardiac Care TORONTO, ON / ACCESS Newswire / November 24, 2025 / NeuralCloud Solutions Inc. ("...
AI/ML Innovations Inc. Announces Grant of U.S. Patent Protecting Core ECG Signal-Processing Architecture
Patent validates AIML's novel neural-network approach to denoising and mapping ECG signals, powering MaxYield™ and CardioYield™. Reinforces competitive advantage as the Company advances commercializat...
AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants to Lead Regulatory Submission for CardioYield(TM) in Jamaica
Collaboration Advances Local Regulatory Pathway for AI-Enabled ECG Diagnostics to Address the Growing Cardiovascular Disease Burden in Jamaica TORONTO, ON / ACCESS Newswire / November 4, 2025 / AI/ML ...
AIML Subsidiary NeuralCloud Solutions Commencing Pilot with Canadian Cardiology Clinic to Advance AI-Powered ECG Reporting
NeuralCloud Solutions to deploy its CardioYield™ platform in a multi-stage pilot program with a full-service cardiology clinic in Canada. Enhance Holter ECG analysis accuracy, efficiency, and workflow...
AIML Subsidiary NeuralCloud Solutions and Heartdent Center Ltd. Launch Pilot Project to Advance Cardiac Care in Jamaica
Pilot Study to Lay the Groundwork for Expansion Across Jamaica Goal of the Collaboration is to Demonstrate the Ability to Deliver Affordable, Accurate, and Scalable Holter Diagnostics with CardioYield...
AIML Subsidiary NeuralCloud Solutions and Toronto Heart Centre Launch a Pilot Program to Test AI-Powered Holter ECG Reporting
Pilot Evaluation: Toronto Heart Centre to conduct comparative testing of CardioYield™ for enhanced Holter ECG analysis and reporting efficiency. Clinical Workflow Impact: Study to measure time savings...
AIML and BC Brain Wellness Program Launch Pilot to Explore the Heart–Brain Connection
Leveraging MaxYield™ ECG to capture real-world exercise data in people living with neurological conditions Generating actionable insights into how cardiac responses may correlate with brain health and...
AIML Announces Closing of Oversubscribed Private Placement
VANCOUVER, BC / ACCESS Newswire / September 22, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that Company completed its previously a...
AIML Announces Proposed Private Placement
VANCOUVER, BC / ACCESS Newswire / September 4, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that it intends to complete a non-broker...
AIML Announces SEDAR Filing
VANCOUVER, BC / ACCESS Newswire / August 21, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is issuing the following press release to clarify its disclosure ...
AIML Innovations Closes Quantum Sciences Ltd. Restructuring
VANCOUVER, BC / ACCESS Newswire / August 8, 2025 / AI/ML Innovations Inc . ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB: 42FB) is pleased to confirm it has closed its previously announced res...
AIML Strengthens IP Portfolio with Provisional Patents for AI Driven ECG Signal Processing
Neural Cloud Solutions, an AIML subsidiary, files broad provisional patent applications covering advanced neural network architectures and cloud‑based ECG signal optimization workflows Filings enhance...
AI/ML Establishes Innovation Committee, Appoints Dr. Drew Dundas as Chair
New board‑level committee will steer regulatory strategy, IP development, and product innovation across AIML's AI‑driven health‑tech portfolio TORONTO, ON / ACCESS Newswire / May 22, 2025 / AI/ML Inno...
AIML Hits Key Regulatory Benchmark with 510(k) Filing for MaxYield(TM) Signal Enhancement Platform
Proprietary neural network, cloud-based AI-powered technology designed to support clearer ECG signal interpretation across care settings. TORONTO, ON / ACCESS Newswire / May 15, 2025 / AI/ML Innovatio...
AIML Innovations Appoints Political Strategist and Public Affairs Leader, Michael Diamond, to Board of Directors
Appointment brings public policy expertise, strategic insight, and business development acumen as AIML accelerates global AI healthcare deployment. VANCOUVER, BC / ACCESS Newswire / May 5, 2025 / AI/M...
AIML Innovations Appoints Jared Adelstein to Board of Directors
Strategic Addition to the Board Strengthens Governance and Accelerates Commercialization Efforts VANCOUVER, BC / ACCESS Newswire / April 22, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") (CS...